Lung Cancer Europe is delighted to welcome another new member to our Executive Team. Chiara Antoniani has been appointed LuCE’s […]
Follow Us
-
+1 700 888 1234
-
Effingerstrasse 40 3008 Bern Switzerland
+1 700 888 1234
Effingerstrasse 40 3008 Bern Switzerland
Lung Cancer Europe is delighted to welcome another new member to our Executive Team. Chiara Antoniani has been appointed LuCE’s […]
Ahead of the upcoming confirmation hearings for EU Health Commissioner-designate Olivér Várhelyi, LuCE wrote to members of the European Parliament […]
Lung Cancer Europe (LuCE) has launched of an important new survey, together with 39 of its Member Organisations.This survey will […]
Bristol Myers Squibb has released a new Press Release announcing that the European Medicines Agency (EMA) has validated the marketing authorization application for repotrectinib. Repotrectinib […]
Financial impact of lung cancer: A European perspective High risk of financial vulnerability after diagnosis: The majority of people impacted […]
November 14th – 15th in Amsterdam We are delighted to announce that Lung Cancer Europe (LuCE) is participating in a two-day meeting […]
consectetur adipisicing elit, sed do eiusmod tempor incididunt laboret dolore magna aliqua. Ut enim minim veniam quis nostrud exercitation ullamco laboris.
Website Under Construction
We are currently rebuilding our website, and look forward to its launch later in 2026.
Until then, this website is not being updated. Feel free to continue browsing, or visit our news site for the latest updates.
